BioCorRx Inc. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001477932-26-003159
- Form type
- 10-Q
- CIK
- 0001443863
- Primary document
- https://www.sec.gov/Archives/edgar/data/1443863/000147793226003159/bicx_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioCorRx Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $214,539 | - | - |
| Cost Of Revenue | $25,184 | - | - |
| Operating Income | $-956,000 | - | - |
| Net Income | $-831,227 | - | - |
| Eps Diluted | -0.03 | - | - |
| Total Assets | $2.3M | - | - |
| Total Liabilities | $13.9M | - | - |
| Shareholders Equity | $-11.5M | - | - |
| Operating Cash Flow | $-432,971 | - | - |